We'll see $1 + in Feb... the financing was done, unfortunately, under seemingly desperate conditions. Nonetheless, the product will meet further approvals at the (slow) discretion of the FDA. As the product's merits and profitability slowly come to light this will likely achieve a market cap in excess of $100MM later in 2013...very high risk, but also high return at 4x current price, with full viability and valuation possible in the $400-600 MM on acquisition in 2014-2016 at 15-23 X current valuation. Surely a lot of positives need to fall in place, but they may.
Good Luck to longs, I know many are in at much higher prices...I scooped some at 0.70, 0.89, 0.93 today, and a LOT higher...Go Manny!